Clinical trial
Randomized Study Comparing Pre- and Postoperative vs. Conventional Adjuvant…
NCT00309569 · Austrian Breast & Colorectal Cancer Study Group, Other · Completed
Key facts
| NCT number | NCT00309569 |
|---|---|
| Title | Randomized Study Comparing Pre- and Postoperative vs. Conventional Adjuvant Treatment in Receptor-negative Patients |
| Official title | A Randomized Phase III Study Comparing Pre- and Postoperative vs. Conventional Adjuvant Treatment Hormone Receptor-negative Breast Cancer Patients |
| Lead sponsor | Austrian Breast & Colorectal Cancer Study Group, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Early Stage Breast Cancer |
| Intervention type | Drug, Other |
| Interventions | Cyclophosphamide, Methotrexate, Fluorouracil, Epirubicin, Surgery |
| Enrollment | 429 |
| Start date | Oct 1, 1991 |
| Primary completion | Sep 1, 2000 |
| Completion | Sep 1, 2000 |
| First posted | Apr 3, 2006 |
| Last update posted | Oct 14, 2020 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: